Cited by 283HIV Research and TreatmentHIV/AIDS Research and InterventionsInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.

Open access

Robb, Merlin L., Eller, Leigh A., Kibuuka, Hannah, Rono, Kathleen, Maganga, Lucas, Nitayaphan, Sorachai, Kroon, Eugene, Sawe, Fred K., Sinei, Samuel, Sriplienchan, Somchai, Jagodzinski, Linda L., Malia, Jennifer, Manak, Mark, de Souza, Mark S., Tovanabutra, Sodsai, Sanders-Buell, Eric, Rolland, Morgane, Dorsey-Spitz, Julie, Eller, Michael A., Milazzo, Mark, Li, Qun, Lewandowski, Andrew, Wu, Hao, Swann, Edith, O’Connell, Robert J., Peel, Sheila, Dawson, Peter, Kim, Jerome H., Michael, Nelson L.·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1508952PMC PMC5111628

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Acute human immunodeficiency virus type 1 (HIV-1) infection is a major contributor to transmission of HIV-1. An understanding of acute HIV-1 infection may be important in the development of treatment strategies to eradicate HIV-1 or achieve a functional cure. METHODS: We performed twice-weekly qualitative plasma HIV-1 RNA nucleic acid testing in 2276 volunteers who were at high risk for HIV-1 infection. For participants in whom acute HIV-1 infection was detected, clinical observations, quantitative measurements of plasma HIV-1 RNA levels (to assess viremia) and HIV antibodies, and results of immunophenotyping of lymphocytes were obtained twice weekly. RESULTS: Fifty of 112 volunteers with acute HIV-1 infection had two or more blood samples collected before HIV-1 antibodies were detected. The median peak viremia (6.7 log10 copies per milliliter) occurred 13 days after the first sample showed reactivity on nucleic acid testing. Reactivity on an enzyme immunoassay occurred at a median of 14 days. The nadir of viremia (4.3 log10 copies per milliliter) occurred at a median of 31 days and was nearly equivalent to the viral-load set point, the steady-state viremia that persists durably after resolution of acute viremia (median plasma HIV-1 RNA level, 4.4 log10 copies per milliliter). The peak viremia and downslope were correlated with the viral-load set point. Clinical manifestations of acute HIV-1 infection were most common just before and at the time of peak viremia. A median of one symptom of acute HIV-1 infection was recorded at a median of two study visits, and a median of one sign of acute HIV-1 infection was recorded at a median of three visits. CONCLUSIONS: The viral-load set point occurred at a median of 31 days after the first detection of plasma viremia and correlated with peak viremia. Few symptoms and signs were observed during acute HIV-1 infection, and they were most common before peak viremia. (Funded by the Department of Defense and the National Institute of Allergy and Infectious Diseases.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1508952

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Dynamics of HIV viremia and antibody seroconversion in plasma donors
Fiebig, E. W., Wright, D. J., Rawal, B. D., Garrett, P. E., Schumacher, R. T., Peddada, L., Heldebrant, C. M., Smith, R., Conrad, A. J., Kleinman, S. H., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00005 · Cited by 1,306
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Sáez‐Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fènoël, V., Girault, I., Lécuroux, C., Potard, V., Versmisse, P., Mélard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,012
Clinical and epidemiologic features of primary HIV infection.
Schacker, T., Collier, A. C., Hughes, J., Shea, T., & Corey, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00001 · Cited by 703
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
Pilcher, C. D., Tien, H. C., Eron, J. J., Vernazza, P., Leu, S., Stewart, P. W., Goh, L., & Cohen, M. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/386333 · Cited by 663
High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection
BRENNER, B. G., Roger, M., Routy, J., Moisi, D. D., Ntemgwa, M. L., Matte, C., Baril, J.-G., Thomas, R., Rouleau, D., Bruneau, J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512088 · Cited by 637
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L. B., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling, T. R., Vlahov, D., Astemborski, J. A., Hoover, D. R., Margolick, J. B., & Quinn, T. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441003 · Cited by 357

Show all 39 references

Sorted by citations

Items 101–200 of 274

Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy
Schuster, C., Mayer, F., Wohlfahrt, C., Marculescu, R., Skoll, M., Straßl, R. P., Pávó, N., Popow‐Kraupp, T., Hülsmann, M., Bauer, M., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy183 · Cited by 17
No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience
Stekler, J. D., Tapia, K. A., Maenza, J. R., Stevens, C. E., Ure, G., O’Neal, J. D., Lane, A., Mullins, J. I., Coombs, R. W., Holte, S., et al. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0276 · Cited by 17
Elevated HIV Viral Load is Associated with Higher Recombination Rate In Vivo
Romero, E. V., & Feder, A. F. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad260 · Cited by 16
Cardiopatía isquémica en el VIH: profundizando en el conocimiento del riesgo cardiovascular
Raposeiras‐Roubín, S., & Triant, V. A. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.08.035 · Cited by 16
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
Mitchell, J. L., Pollara, J., Dietze, K. A., Edwards, R. W., Nohara, J., N’guessan, K. F., Zemil, M., Buranapraditkun, S., Takata, H., Li, Y., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150937 · Cited by 16
Self-citation
Third-trimester repeat HIV testing: it is time we make it universal
Cassimatis, I. R., Ayala, L. D., Miller, E. S., Garcia, P. M., Jao, J. K., & Yee, L. M. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.04.250 · Cited by 16
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation
Crowell, T. A., Ritz, J., Coombs, R. W., Zheng, L., Eron, J. J., Mellors, J. W., Dragavon, J., van Zyl, G. U., Lama, J. R., Ruxrungtham, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1893 · Cited by 15
Self-citation
Effect of an opt-out point-of-care HIV-1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomized controlled trial
Sanders, E. J., Agutu, C., van der Elst, E., Hassan, A., Gichuru, E., Mugo, P., Farquhar, C., Babigumira, J. B., Goodreau, S. M., Hamilton, D. T., et al. (2022) · HIV Medicine · doi:10.1111/hiv.13157 · Cited by 15
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
Ndung’u, T., Dong, K. L., Colby, D. J., Deeks, S. G., Cotton, M. F., Dubé, K., Goulder, P., Jülg, B. D., Nsubuga, M. S., Ajibola, G., et al. (2026) · The Lancet HIV · doi:10.1016/s2352-3018(25)00373-x · Cited by 14
Acute HIV-1 Infection: Paradigm and Singularity
Chéret, A. (2025) · Viruses · doi:10.3390/v17030366 · Cited by 14
The dynamics of simian immunodeficiency virus after depletion of CD8+ cells
Ojeda, E. F. C., Apetrei, C., Pandrea, I., & Ribeiro, R. M. (2018) · Immunological Reviews · doi:10.1111/imr.12691 · Cited by 14
Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART
Brooks, K., Omondi, F. H., Liang, R. H., Sudderuddin, H., Jones, B. R., Joy, J. B., Brumme, C. J., Hunter, E., & Brumme, Z. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.719153 · Cited by 14
The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?
Lee, S. A., & Deeks, S. G. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.009 · Cited by 14
Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk
Raposeiras‐Roubín, S., & Triant, V. A. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.10.005 · Cited by 14
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-Infection Estimation towards Enhanced Vaccine Efficacy Assessment
Rossenkhan, R., Rolland, M., Labuschagne, J. P. L., Ferreira, R.-C., Magaret, C. A., Carpp, L. N., Matsen, F. A., IV, Huang, Y., Rudnicki, E., Zhang, Y., et al. (2019) · Viruses · doi:10.3390/v11070607 · Cited by 14
Self-citation
Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes
Suanzes, P., Navarro, J., Rando‐Segura, A., Álvarez‐López, P., Garcia, J. N., Descalzo, V., Monforte, A., Arando, M., Rodríguez, L., Planas, B., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.09.009 · Cited by 15
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study
Marichannegowda, M. H., Zemil, M., Wieczorek, L., Sanders‐Buell, E., Bose, M., O’Sullivan, A. M., King, D. B., Francisco, L., Diaz‐Mendez, F., Setua, S., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104867 · Cited by 14
Self-citation
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype
Marichannegowda, M. H., Setua, S., Bose, M., Sanders‐Buell, E., King, D. B., Zemil, M., Wieczorek, L., Diaz‐Mendez, F., Chomont, N., Thomas, R., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105410 · Cited by 14
Self-citation
Epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in Barcelona, Spain (1997–2015): a prospective cohort study
Nicolás, D., Ambrosioni, J., de Lazzari, E., Suarez, A., Manzardo, C., Agüero, F., Mosquera, M. M., Costa, J. M., Ligero, C., Marcos, M. Á., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.10.021 · Cited by 13
Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection
Chissumba, R. M., Namalango, E., Maphossa, V., Macicame, I., Bhatt, N., Polyak, C. S., Robb, M. L., Michael, N. L., Jani, I. V., & Kestens, L. (2017) · BMC Immunology · doi:10.1186/s12865-017-0235-7 · Cited by 13
Self-citation
Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand
Chintanaphol, M., Sacdalan, C., Chottanapund, S., Pinyakorn, S., Buranapraditkun, S., Crowell, T. A., Kroon, E. D. M. B., Manasnayakorn, S., Chipman, J. G., Schacker, T. W., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001780 · Cited by 13
Self-citation
Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model
Kasaie, P., Berry, S. A., Shah, M., Rosenberg, E. S., Hoover, K. W., Gift, T. L., Chesson, H. W., Pennington, J., German, D., Flynn, C. P., et al. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000882 · Cited by 13
The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
Zhu, J., Rozada, I., David, J., Moore, D. M., Guillemi, S. A., Barrios, R., Montaner, J. S. G., & Lima, V. D. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.07.001 · Cited by 13
HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
Kammers, K., Chen, A., Monaco, D. R., Hudelson, S. E., Grant‐McAuley, W., Moore, R. D., Alter, G., Deeks, S. G., MORRISON, C. S., Eller, L. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740395 · Cited by 13
Self-citation
Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir
Prévost, J., Chen, Y., Zhou, F., Tolbert, W. D., Gasser, R., Medjahed, H., Nayrac, M., Nguyen, D. N. P., Gottumukkala, S., Hessell, A. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42500-2 · Cited by 12
Cost-effectiveness of increased HIV testing among MSM in The Netherlands
Reitsema, M., Steffers, L., Visser, M., Heijne, J. C. M., van Hoek, A. J., van der Loeff, M. F. S., van Sighem, A., BENTHEM, B. H. B. V., Wallinga, J., Xiridou, M., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002199 · Cited by 12
Expansion of Stem Cell-Like CD4+Memory T Cells during Acute HIV-1 Infection Is Linked to Rapid Disease Progression
Pušnik, J., Eller, M. A., Tassaneetrithep, B., Schultz, B. T., Eller, L. A., Nitayaphan, S., Kosgei, J., Maganga, L., Kibuuka, H. N., Alter, G., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00377-19 · Cited by 12
Self-citation
Acute HIV-1 Infection in Adults in East Africa and Thailand
Robb, M. L., Eller, L. A., & Rolland, M. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1609157 · Cited by 12
Self-citation
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation
Gabert, R., Lama, J. R., Valdez, R., Dasgupta, S., Cabello, R. L., Sanchez, H., León, M., Valencia-Huamaní, J., MacRae, J., Montalbán, E., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003511 · Cited by 11
Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States
Neilan, A. M., Bulteel, A. J. B., Hosek, S., Foote, J. H. A., Freedberg, K. A., Landovitz, R. J., Walensky, R. P., Resch, S., Kazemian, P., Paltiel, A. D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1061 · Cited by 11
Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays
Klock, E., Mwinnya, G., Eller, L. A., Fernández, R. E., Kibuuka, H. N., Nitayaphan, S., Kosgei, J., Moore, R. D., Robb, M. L., Eshleman, S. H., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2019.0286 · Cited by 10
Self-citation
Preferential and persistent impact of acute HIV-1 infection on CD4 + iNKT cells in colonic mucosa
Paquin‐Proulx, D., Lal, K. G., Phuang‐Ngern, Y., Creegan, M., Tokarev, A., Suhkumvittaya, S., Alrubayyi, A., Kroon, E. D. M. B., Pinyakorn, S., Slike, B. M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104721118 · Cited by 10
Self-citation
Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers
Brett‐Major, D. M., Scott, P. T., Crowell, T. A., Polyak, C. S., Modjarrad, K., Robb, M. L., & Blazes, D. L. (2016) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-016-0042-9 · Cited by 10
Self-citation
Novel homo Yin-Yang probes improve sensitivity in RT-qPCR detection of low copy HIV RNA
Farzan, V. M., Kvach, M. V., Aparin, I. O., Евгеньевич, К. Д., Prikazchikova, T. A., Ustinov, A. V., Shmanai, V. V., Shipulin, G. A., Korshun, V. A., & Zatsepin, T. S. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.043 · Cited by 10
Humoral Response to the HIV-1 Envelope V2 Region in a Thai Early Acute Infection Cohort
Trinh, H. V., Gohain, N., Pham, P. T., Hamlin, C., Song, H., Sanders‐Buell, E., Bose, M., Eller, L. A., Tovanabutra, S., Michael, N. L., et al. (2019) · Cells · doi:10.3390/cells8040365 · Cited by 10
Self-citation
Modeling dynamics of acute HIV infection incorporating density-dependent cell death and multiplicity of infection
Mainou, E., Ribeiro, R. M., & Conway, J. M. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012129 · Cited by 9
Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay
Manak, M., Eller, L. A., Malia, J. A., Jagodzinski, L. L., Trichavaroj, R., Oundo, J. O., Lueer, C., Cham, F., de Souza, M. S., Michael, N. L., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00431-17 · Cited by 9
Self-citation
Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones
Chenine, A.-L., Merbah, M., Wieczorek, L., Molnar, S., Mann, B. T., Lee, J., O’Sullivan, A. M., Bose, M., Sanders‐Buell, E., Kijak, G. H., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001675 · Cited by 9
Self-citation
Hepatitis and tuberculosis testing are much less common than HIV testing among adults in Kisumu, Kenya: results from a cross-sectional assessment
Tunnage, J., Yates, A. M., Nwoga, C., Sing’oei, V., Owuoth, J., Polyak, C. S., Crowell, T. A., for the RV393 Study Group, Adongo, R., Aguttu, R., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-11164-2 · Cited by 9
Self-citation
Prospecting for an HIV vaccine
Brett‐Major, D. M., Crowell, T. A., & Michael, N. L. (2017) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-017-0050-4 · Cited by 9
Self-citation
Estimation of the Seroconversion Duration of HIV-1 Antibodies in Individuals With Recent Infection in China
Kong, W., Liu, P., Tang, L., Zhu, Z., Xiao, P., Zhan, J., Wang, X., Zhou, W., & Liu, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01322 · Cited by 9
Changing roles of CD3+CD8low T cells in combating HIV-1 infection
Zhang, X., Wang, X., Qin, L., Lu, X., Liu, Z., Li, Z., Yuan, L., Wang, R., Jin, J., Ma, Z., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002458 · Cited by 8
Self-citation
HIV diagnosis during acute infection: implications of long-acting preexposure prophylaxis and other evolving challenges
Elliott, T., Bradshaw, D., & Fidler, S. J. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000919 · Cited by 8
Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against Plasmodium and Anopheles Antigens
Chaudhury, S., Bolton, J. S., Eller, L. A., Robb, M. L., Ake, J. A., Ngauy, V., Regules, J. A., Kamau, E. T., & Bergmann‐Leitner, E. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071839 · Cited by 8
Self-citation
Differences in Risk Behavior and Demographic Factors Between Men Who Have Sex With Men With Acute and Nonacute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles
Davey, D. J., Beymer, M. R., Roberts, C. P., Bolan, R., & Klausner, J. D. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001233 · Cited by 8
Chapter 6 Non–Squamous Cell Causes of Cervical Lymphadenopathy
Agarwal, M., Nabavizadeh, S. A., & Suyash, M. (2017) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2017.05.006 · Cited by 8
Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection
Gilbertson, A., Tucker, J. D., Dubé, K., Dijkstra, M., & Rennie, S. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00716-1 · Cited by 8
Pilot testing of an online training module about screening for acute HIV infection in adult patients seeking urgent healthcare
Rafferty, H., Chirro, O., Oduor, C., Wahome, E., Ngoi, C., van der Elst, E., Berger, R., Rowland‐Jones, S., Graham, S. M., & Sanders, E. J. (2018) · International Health · doi:10.1093/inthealth/ihy077 · Cited by 8
Integrase Strand Transfer Inhibitors Play the Main Role in Greater Weight Gain Among Men With Acute and Early HIV Infection
Wu, K.-S., Anderson, C. M., & Little, S. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa619 · Cited by 8
HIV-1 infections with multiple founders associate with the development of neutralization breadth
Lewitus, É., Townsley, S., Li, Y., Donofrio, G. C., Dearlove, B. L., Bai, H., Sanders‐Buell, E., O’Sullivan, A. M., Bose, M., Kibuuka, H. N., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010369 · Cited by 8
Self-citation
Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay
Routy, J., & Mehraj, V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.08.38 · Cited by 8
Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies
Kasibante, J., Brown, T. T., Lake, J. E., & Abdel‐Mohsen, M. (2025) · Comprehensive physiology · doi:10.1002/cph4.70050 · Cited by 7
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection
Mullins, J. I., Deng, W., Giorgi, E. E., Magaret, C. A., Rolland, M., Tanmoy Bhattacharya, A., Westfall, D. H., Yssel, A., Bumgarner, R. E., Murrell, B., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73496-0 · Cited by 7
Self-citation
Per-pathogen virulence of HIV-1 subtypes A, C and D
Bouman, J. A., Venner, C. M., Walker, C., Arts, E. J., & Regoes, R. R. (2023) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.2572 · Cited by 7
Identification of a circulating long non-coding RNA signature panel in plasma as a novel biomarker for the detection of acute/early-stage HIV-1 infection
Biswas, S., Nagarajan, N., HEWLETT, I. K., & Devadas, K. (2024) · Biomarker Research · doi:10.1186/s40364-024-00597-7 · Cited by 7
The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease
Rindler, A., Kusejko, K., Kuster, H., Neumann, K., Leemann, C., Zeeb, M., Chaudron, S. E., Braun, D. L., Kouyos, R. D., Metzner, K. J., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac100 · Cited by 7
Molecular Mechanisms of HIV-1 Latency from a Chromatin and Epigenetic Perspective
Jütte, B. B., Love, L., & Svensson, J. P. (2023) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00208-3 · Cited by 7
Relational concurrency, stages of infection, and the evolution of HIV set point viral load
Goodreau, S. M., Stansfield, S. E., Murphy, J. T., Peebles, K., Gottlieb, G. S., Abernethy, N. F., Herbeck, J. T., & Mittler, J. E. (2018) · Virus Evolution · doi:10.1093/ve/vey032 · Cited by 7
Factors influencing estimates of HIV-1 infection timing using BEAST
Dearlove, B. L., Tovanabutra, S., Owen, C. L., Lewitus, É., Li, Y., Sanders‐Buell, E., Bose, M., O’Sullivan, A. M., Kijak, G. H., Miller, S., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008537 · Cited by 9
Self-citation
Activation of CXCR3 + Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development
Mitchell, J. L., Buranapraditkun, S., Gantner, P., Takata, H., Dietze, K. A., N’Guessan, K. F., Pollara, J., Nohara, J., Muir, R., Kroon, E. D. M. B., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01532-24 · Cited by 6
Self-citation
Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection
Tarrés-Freixas, F., Trinité, B., Carrillo, J., & Blanco, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311381 · Cited by 6
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth
Li, Y., Bai, H., Sanders‐Buell, E., Dussupt, V., Townsley, S., Donofrio, G. C., Bose, M., O’Sullivan, A. M., Kibuuka, H. N., Maganga, L., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00797-21 · Cited by 6
Self-citation
Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era
Vieira, V., Herbert, N. G., Cromhout, G., Adland, E., & Goulder, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886562 · Cited by 6
Brain volumetrics differ by Fiebig stage in acute HIV infection
Bolzenius, J. D., Sacdalan, C., Ndhlovu, L. C., Sailasuta, N., Trautmann, L., Tipsuk, S., Crowell, T. A., Suttichom, D., Colby, D. J., Phanuphak, N., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003496 · Cited by 6
Self-citation
Sustained Reduction in Sexual Behavior that May Pose a Risk of HIV Transmission Following Diagnosis During Early HIV Infection Among Gay Men in Vancouver, British Columbia
Gilbert, M., Taylor, D., Michelow, W., Grace, D., Balshaw, R. F., Kwag, M., Lim, E., Fischer, B., Patrick, D. M., Ogilvie, G. S., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1702-0 · Cited by 6
Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand
Kroon, E. D. M. B., Pham, P. T., Sirivichayakul, S., Trichavaroj, R., Colby, D. J., Pinyakorn, S., Phanuphak, N., Sanders‐Buell, E., van Griensven, F., Kijak, G. H., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001956 · Cited by 6
Self-citation
Point-of-care HIV RNA testing and immediate antiretroviral therapy initiation in young adults seeking out-patient care in Kenya
Sanders, E. J., Chirro, O., Oduor, C., Mangi, J., Wahome, E., Price, M. A., Gelderblom, H. C., van der Elst, E. M., & Graham, S. M. (2018) · AIDS · doi:10.1097/qad.0000000000002110 · Cited by 6
Defining Kinetic Properties of HIV-Specific CD8+ T-Cell Responses in Acute Infection
Yang, Y., & Ganusov, V. V. (2019) · Microorganisms · doi:10.3390/microorganisms7030069 · Cited by 6
Prevalence, clinical characteristics and outcome of severe primary HIV-1 infection: A prospective cohort study
Nicolás, D., Suárez‐Pérez, A., Ambrosioni, J., Manzardo, C., Ligero, C., Costa, J. M., Fernández, E., Marcos, M. Á., Plana, M., Mosquera, M. M., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.08.001 · Cited by 9
HIV Testing in Adults Presenting With Central Nervous System Infections
Ma, B., Vigil, K. J., & Hasbun, R. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa217 · Cited by 6
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials
Williamson, C. E., Moodley, C., Magaret, C. A., Giorgi, E. E., Rolland, M., Westfall, D. H., Yssel, A., Deng, W., Rossenkhan, R., Mkhize, N. N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70888-0 · Cited by 5
Self-citation
Clinical performance evaluation of an HIV Duo assay: From HIV screening to acute and non-acute HIV infection detection
Liu, X., Wu, C., Yuan, Y., Li, D., Lou, J., Feng, X., Lu, Q., Wu, R., Chen, A.-J., & Tao, C. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119949 · Cited by 5
Acute retroviral syndrome
Lama, J. R., Ignacio, R. B., & Duerr, A. C. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000933 · Cited by 5
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth
Griffith, G. L., Machmach, K., Jian, N., Kim, D., Costanzo, M. C., Creegan, M., Swafford, I., Kundu, G., Yum, L. K., Bolton, J. S., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012916 · Cited by 5
Self-citation
The Clinical Spectrum of Human Immunodeficiency Virus Infection
Stingone, C., Sarmati, L., & Andreoni, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-02200-6_15 · Cited by 5
Functional cure of a chronic virus infection by shifting the virus - host equilibrium state
Bocharov, G. A., Grebennikov, D. S., Rica, P. C., Domenjo‐Vila, E., Casella, V., & Meyerhans, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904342 · Cited by 5
Más allá de los síntomas: vivir con VIH es motor de cambio
Erazo, A. M. B., & Canaval, G. E. (2018) · Avances en Enfermería · doi:10.15446/av.enferm.v36n3.71588 · Cited by 5
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
Gift, S. K., Wieczorek, L., Sanders‐Buell, E., Zemil, M., Molnar, S., Donofrio, G. C., Townsley, S., Chénine, A. L., Bose, M., Trinh, H. V., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01635-22 · Cited by 5
Self-citation
Acute Appendicitis as the Initial Clinical Presentation of Primary HIV-1 Infection
Schleimann, M. H., Leth, S., Krarup, A. R., Mortensen, J., Barstad, B., Zaccarin, M., Denton, P. W., & Mohey, R. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy006 · Cited by 5
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption
Mdluli, T., Slike, B. M., Curtis, D. J., Shubin, Z., Tran, U., Li, Y., Dussupt, V., Mendez-Rivera, L., Pinyakorn, S., Stieh, D. J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114344 · Cited by 4
Self-citation
The utility of nonhuman primate models for understanding acute HIV-1 infection
Parsons, M. S., & Bolton, D. L. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000920 · Cited by 4
Bayesian estimation of HIV acquisition dates for prevention trials
Rossenkhan, R., Giorgi, E. E., Shao, D., Ludwig, J., Labuschagne, J. P. L., Magaret, C. A., Ndung’u, T., Muema, D., Gounder, K., Dong, K. L., et al. (2025) · mBio · doi:10.1128/mbio.01881-25 · Cited by 4
Self-citation
Clinical trial simulation of antiviral drugs
Schiffer, J. T., Reeves, D. B., Mayer, B. T., Rodriguez, L. R., Duke, E. R., Haddock, B., de León, U. A.-P., Iwami, S., Owens, K. L., & Esmaeili, S. (2026) · Journal of Virology · doi:10.1128/jvi.01814-24 · Cited by 4
A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults
Jiménez, M., Pastor, L., Urrea, V., de la Concepción, M. L. R., Parker, E., de la Fuente, L., Jairoce, C., Mandomando, I., Carrillo, J., Naniche, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614319 · Cited by 4
Significance of initiating antiretroviral therapy in the early stage of HIV infection
Shao, Y., Xun, J., Chen, J., & Lu, H. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0052 · Cited by 4
A novel internet sampling for HIV surveillance: feasibility of self-sampling and preparation of DBS for delivery detection of HIV total nucleic acid and complementarity to sentinel surveillance
Su, X., Xia, D., Sun, Y., Hao, Y., Liu, G., Huang, C., & Lu, H. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08456-w · Cited by 4
The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS
Reinaldo, L. G. C., Júnior, R. J. C. A., Diniz, T. M., Moura, R. D. D., Filho, A. J. M., Furtado, C. V. V. M., dos‐Santos, W. L. C., Costa, D. L., Eulálio, K. D., Ferreira, G. R., et al. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06151-6 · Cited by 4
Characterizing HIV Acquisition Risk, Treatment Gaps, and Populations Reached Through Venue-Based Outreach and Clinical Services in Blantyre, Malawi: Findings From a District-wide CLOVE Study
Singogo, E., Weir, S. S., Kudowa, E., Chagomerana, M., Chapola, J. C., Edwards, J. K., Banda, C., Kawalazira, G., Kamgwira, Y., Jahn, A., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003493 · Cited by 4
Longitudinal Analysis of Peripheral and Colonic CD161+ CD4+ T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation
Lal, K. G., Phuang‐Ngern, Y., Suhkumvittaya, S., Leeansyah, E., Alrubayyi, A., Dias, J., Waickman, A. T., Kim, D., Kroon, E. D. M. B., Pinyakorn, S., et al. (2020) · Viruses · doi:10.3390/v12121426 · Cited by 4
Self-citation
Clinical signs and symptoms associated with acute HIV infection from an intensely monitored cohort on 2 continents
Letizia, A. G., Eller, L. A., Bryant, C., Dawson, P., Nitayaphan, S., Kosgei, J., Kibuuka, H., Maganga, L., Kroon, E. D. M. B., Sriplienchan, S., et al. (2022) · Medicine · doi:10.1097/md.0000000000028686 · Cited by 4
Self-citation
Epigenetic reprogramming of the host immune system during acute HIV
Pang, A. P. S., & Corley, M. J. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000935 · Cited by 3
The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States
Manabe, Y. C., Hamill, M. M., Palamountain, K. M., Achenbach, C. J., Delaney, K. P., Hsieh, Y., Jones, J. L., Kirby, R. P., McFall, S. M., Osburn, W. O., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf510 · Cited by 3
A long-standing undiagnosed case of vitamin B12 deficiency: a case report
Mesgarankarimi, A., Rezapour, M., & Tabrizi, N. (2025) · Journal of Medical Case Reports · doi:10.1186/s13256-025-05149-7 · Cited by 3
NK cell activation and CD4+ T cell α4β7 expression are associated with susceptibility to HIV-1
Machmach, K., N’Guessan, K. F., Farmer, R., Godbole, S., Kim, D., McCormick, L., Lima, N. S., Henry, A. R., Laboune, F., Swafford, I., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci187992 · Cited by 3
Self-citation
Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations
Wiener, H. W., Shrestha, S., Lu, H., Karita, E., Kilembe, W., Allen, S. A., Hunter, E., Goepfert, P., & Tang, J. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.12.005 · Cited by 3
Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens
Lewitus, É., Hoang, J., Li, Y., Bai, H., & Rolland, M. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010624 · Cited by 3
Self-citation
A More Comprehensive Clinical and Laboratory Characterization of 61 Acute HIV Infection Patients in Southwest China
Shi, W., Yang, M., Wei, Y., Tang, Z., Luo, L. F., Deng, J., & Tao, C. (2023) · Pathogens · doi:10.3390/pathogens12010142 · Cited by 3
Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies
Mudd, J. C. (2024) · Viruses · doi:10.3390/v16040514 · Cited by 3
Viral kinetics among persons living with HIV (PLWH) on Dolutegravir-based antiretroviral Regimen: A retrospective and prospective analysis from selected HIV clinics in Ghana
Nyarko, S. B., Twum, J. A., Obeng, A. S., Djangba, H. D., Debrah, O., Kyei, F., Kyei, G. B., & Thomford, N. E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324360 · Cited by 3
Factors Associated with Medication Adherence for People Living with Acute HIV Infection in a Tertiary Chinese Hospital in Beijing
Wang, X., Li, D., Gao, M., Zhou, Y., Guo, C., Zhang, T., Zhang, L., & Wang, W. (2021) · BioMed Research International · doi:10.1155/2021/1078716 · Cited by 3

Authors: Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., Jagodzinski, L. L., Malia, J., Manak, M., de Souza, M. S., Tovanabutra, S., Sanders-Buell, E., Rolland, M., Dorsey-Spitz, J., Eller, M. A., Milazzo, M., Li, Q., Lewandowski, A., Wu, H., Swann, E., O’Connell, R. J., Peel, S., Dawson, P., Kim, J. H., & Michael, N. L.
Affiliations: Henry M. Jackson Foundation (US)
Armed Forces Research Institute of Medical Science (TH)
ORCID: Robb, Merlin L.
Eller, Leigh A.
Kibuuka, Hannah
Maganga, Lucas
Nitayaphan, Sorachai
Kroon, Eugene
Sawe, Fred K.
Jagodzinski, Linda L.
Manak, Mark
Tovanabutra, Sodsai
Rolland, Morgane
Eller, Michael A.
Milazzo, Mark
Li, Qun
Lewandowski, Andrew
Wu, Hao
Swann, Edith
O’Connell, Robert J.
Dawson, Peter
Michael, Nelson L.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-06-02
Volume: 374
Issue: 22
Pages: 2120-2130
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1508952
PMC: PMC5111628
OpenAlex: W2402980652
Cited by: 283
References: 39
Citations by year: 2026: 18 · 2025: 25 · 2024: 22 · 2023: 31 · 2022: 23 · 2021: 31 · 2020: 31 · 2019: 23 · 2018: 34 · 2017: 30 · 2016: 14
FWCI: 23.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01ai002642-013)
National Institute of Allergy and Infectious Diseases (Y01 AI002642, Y1-AI-2642-17)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: acute HIV-1 infection, HIV-1 viremia, viral load set point, HIV-1 viral load, HIV-1 antibodies, clinical symptoms and signs, HIV transmission, functional cure, East Africa, Thailand
MeSH terms: Adolescent, Adult, Africa, Eastern, Antibodies, Viral, Female, Humans, Male, Middle Aged, Prospective Studies, RNA, Viral, Thailand, Viremia, HIV-1, HIV Infections, Disease Progression, CD4 Lymphocyte Count, Viral Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks